Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
Details for Australian Patent Application No. 2006286563 (hide)
International Classifications
Event Publications
12 June 2008 PCT application entered the National Phase
PCT publication WO2007/025977 Priority application(s): WO2007/025977
11 December 2008 Alteration of Name
The name of the applicant has been altered to Ablynx N.V.; Actogenix NV
23 February 2012 Application Accepted
Published as AU-B-2006286563
21 June 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006286568-11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
2006286535-Novel cycloalkane carboxamides as factor Xa inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser